Enjoy these exclusive and compelling interviews from researchers around the world studying Crohn’s disease, mycobacteria and chronic immune disease.
Interviews with Dr. Ira Shafran, Dr. William Chamberlin, Dr. Robert Greenstein and John Aitken included.
Coronavirus, IBD, research updates & more! See what’s going on behind the scenes at Human Para and what we have planned for 2020.
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together. Read all the latest news and research about mycobacteria, particularly Mycobacterium avium subsp. paratuberculosis (MAP), and the treatment of Crohn’s and immune disease with AMAT and other innovative therapies. Enjoy!
March 24, 2020 is the 138th anniversary of Dr. Robert Koch’s famous meeting at the Berlin Physiological Society where he presented his findings on tuberculosis to a stunned audience. Researcher John Aitken (Otakaro Pathways, New Zealand) provides fresh insight into this historic event, and why it remains relevant in our fight against Crohn’s and MAP today.
After 3 years as a 501(c)(3) nonprofit, we are proud to report that 93.2% of our spending in 2019 was on innovative human MAP research projects! We continue to have very low overhead expenses due to our amazing volunteer team and the efforts of our researchers. See this 3 year pie chart for more detail on how your donations are put to work.
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together. Read all the latest news and research about mycobacteria, particularly Mycobacterium avium subsp. paratuberculosis (MAP), and the treatment of Crohn’s and immune disease with AMAT and other innovative therapies. Enjoy!
November and December have seen an abundance of new MAP publications by research groups affiliated with Human Para. Research by Otakaro Pathways, Dr. Saleh Naser, Dr. Marcel Behr, Dr. Leonardo Sechi, Dr. Horacio Bach and Dr. C. Thomas Dow are showcased in this update.
Make a difference for those with Crohn’s and other MAP-related conditions this holiday season! Giving Tuesday 2019 is fast approaching on December 3, 2019.
Human Para is raising funds for new MAP research projects. We have been working diligently with Children’s Hospital of Philadelphia, McGill University and Otakaro Pathways on a pilot testing study. As always, ALL funds raised on #GivingTuesday will go directly to MAP research. Please help us by supporting high quality MAP research this giving season.
Human Para’s inaugural MAP testing study is nearing completion. A total of 201 participants donated a blood sample at locations in Orlando, Philadelphia and New York City between May and September 2018. Blinded samples were sent to 6 research laboratories around the world, and MAP testing was completed by a variety of methods, including culture, PCR and antibody assays.
Read about our progress, a Phase 2 add on portion of the study currently being conducted, and when these results will be published!
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together. Read all the latest news and research about mycobacteria, particularly Mycobacterium avium subsp. paratuberculosis (MAP), and the treatment of Crohn’s and immune disease with AMAT and other innovative therapies. Enjoy!
